Sort
51,593 grants matching “hepatitis”
HIV AND THE SEXUAL NETWORKS OF IDUS AND DRUG-USING MSM
$986,118University Of Illinois At Chicago · U01 · FY2004 · DA
HIV Disease Outcomes in Drug Users in Clinical Practice
$985,539Johns Hopkins University · R01 · FY2004 · DA
Systems Biology Approach to Identifying Biomarkers for Alcoholic Liver Disease
$985,241Ali Keshavarzian · Rush University Medical Center · RC2 · FY2010 · AA
Novel therapy for alcoholic liver disease-associated hepatorenal syndrome
$985,224Mani Subramanian · Mitopower Llc · U44 · FY2021 · AA
DIGESTIVE DISEASES RESEARCH CORE CENTERS
$985,001Yale University · P30 · FY2000 · DK
Living in the post-Zika world: Impact of interactions between dengue and Zika viruses on diagnostics, antibody dynamics, and correlates of disease risk
$984,840Eva Harris · University Of California Berkeley · U01 · FY2021 · AI
Development of 7HP349, an oral integrin activator to enhance therapeutic responses to immune checkpoint inhibitors
$984,409Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2020 · CA
Development of a Novel MRI Contrast Agent for Early Detection of Alcoholic Steatohepatitis
$984,309Jenny J Yang · Inlighta Biosciences, Llc · UT2 · FY2021 · AA
HIV Risk and Neighborhood Networks of New IDUs
$984,167National Development &Res Institutes · R01 · FY2005 · DA
Proteasome inhibitor re-sensitizing molecules for treatment of refractory multiple myeloma
$984,129Frank W. Marcoux · Leukogene Therapeutics, Inc. · R42 · FY2018 · CA
A single antiviral to treat multiple opportunistic infections
$983,882Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2024 · AI
Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE)
$983,737William Edward Soares · Baystate Medical Center, Inc. · UH3 · FY2021 · DA
Epigenomic Biomarkers of HIV-Associated Cancers in Nigeria
$983,472Lifang Hou · Northwestern University At Chicago · U54 · FY2019 · CA
Studies of Rare Cancers
$983,415Louise Brinton · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$983,087Mary N. Carrington · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
High Tc susceptometer for magnetic measure of body iron
$983,010Columbia University Health Sciences · R01 · FY2004 · DK
Activated Sugars, Oligosaccharides and Glycans for Antiviral Research
$982,971Leila Aminova · Midwest Bioprocessing Center, Llc · R44 · FY2021 · GM
A Precision Medicine for Alcohol-Associated Liver Disease
$982,659Wanqing Liu · Genetobe Inc. · UT2 · FY2024 · AA
A Therapeutic Vaccine for Chronic Hepatitis B
$982,569David R. Milich · Vlp Biotech, Inc. · R44 · FY2013 · AI
Subcutaneous Drug Development for Portal Hypertension Ascites
$982,292Gerardo M. Castillo · Pharmain Corporation · R44 · FY2022 · DK
Characterizing Alcohol's Effects on Repair of Liver Injury
$981,625Anna Mae Elizabeth Diehl · Duke University · RC2 · FY2010 · AA
HIV Disease Outcomes in Drug Users in Clinical Practice
$981,603Johns Hopkins University · R01 · FY2003 · DA
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$981,463Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
A Therapeutic Vaccine for Chronic Hepatitis B
$981,428David R. Milich · Vlp Biotech, Inc. · R44 · FY2014 · AI
Hepatic Growth Factor Mimetic for Liver Fibrosis
$981,340Angion Biomedica Corporation · R44 · FY2004 · AA